Literature DB >> 1704150

Inability of malaria vaccine to induce antibodies to a protective epitope within its sequence.

Y Charoenvit1, W E Collins, T R Jones, P Millet, L Yuan, G H Campbell, R L Beaudoin, J R Broderson, S L Hoffman.   

Abstract

Saimiri monkeys immunized with a recombinant protein containing 20 copies of the nine amino acid repeat of the Plasmodium vivax circumsporozoite (CS) protein developed high concentrations of antibodies to the repeat sequence and to sporozoites, but were not protected against challenge. After intravenous injection of an immunoglobulin G3 monoclonal antibody (NVS3) against irradiated P. vivax sporozoites, four of six monkeys were protected against sporozoite-induced malaria, and the remaining two animals took significantly longer to become parasitemic. Epitope mapping demonstrated that NVS3 recognizes only four (AGDR) of the nine amino acids within the repeat region of the P. vivax CS protein. The monkeys immunized with (DRAADGQPAG)20 did not produce antibodies to the protective epitope AGDR. Thus, determination of the fine specificity of protective immune responses may be critical to the construction of successful subunit vaccines.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1704150     DOI: 10.1126/science.1704150

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  30 in total

1.  Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction.

Authors:  James J Moon; Heikyung Suh; Adrienne V Li; Christian F Ockenhouse; Anjali Yadava; Darrell J Irvine
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-12       Impact factor: 11.205

2.  Prevention and treatment of vivax malaria.

Authors:  J Kevin Baird; Eli Schwartz; Stephen L Hoffman
Journal:  Curr Infect Dis Rep       Date:  2007-01       Impact factor: 3.725

3.  Mouse model for exoerythrocytic stages of Plasmodium falciparum malaria parasite.

Authors:  J B Sacci; M E Schriefer; J H Resau; R A Wirtz; L J Detolla; R B Markham; A F Azad
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

4.  CD4(+) T-cell- and gamma interferon-dependent protection against murine malaria by immunization with linear synthetic peptides from a Plasmodium yoelii 17-kilodalton hepatocyte erythrocyte protein.

Authors:  Y Charoenvit; V F Majam; G Corradin; J B Sacci; R Wang; D L Doolan; T R Jones; E Abot; M E Patarroyo; F Guzman; S L Hoffman
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

5.  Protection against malaria at 1 year and immune correlates following PfSPZ vaccination.

Authors:  Andrew S Ishizuka; Kirsten E Lyke; Adam DeZure; Andrea A Berry; Thomas L Richie; Floreliz H Mendoza; Mary E Enama; Ingelise J Gordon; Lee-Jah Chang; Uzma N Sarwar; Kathryn L Zephir; LaSonji A Holman; Eric R James; Peter F Billingsley; Anusha Gunasekera; Sumana Chakravarty; Anita Manoj; MingLin Li; Adam J Ruben; Tao Li; Abraham G Eappen; Richard E Stafford; Natasha K C; Tooba Murshedkar; Hope DeCederfelt; Sarah H Plummer; Cynthia S Hendel; Laura Novik; Pamela J M Costner; Jamie G Saunders; Matthew B Laurens; Christopher V Plowe; Barbara Flynn; William R Whalen; J P Todd; Jay Noor; Srinivas Rao; Kailan Sierra-Davidson; Geoffrey M Lynn; Judith E Epstein; Margaret A Kemp; Gary A Fahle; Sebastian A Mikolajczak; Matthew Fishbaugher; Brandon K Sack; Stefan H I Kappe; Silas A Davidson; Lindsey S Garver; Niklas K Björkström; Martha C Nason; Barney S Graham; Mario Roederer; B Kim Lee Sim; Stephen L Hoffman; Julie E Ledgerwood; Robert A Seder
Journal:  Nat Med       Date:  2016-05-09       Impact factor: 53.440

6.  Development of two monoclonal antibodies against Plasmodium falciparum sporozoite surface protein 2 and mapping of B-cell epitopes.

Authors:  Y Charoenvit; V Fallarme; W O Rogers; J B Sacci; M Kaur; J C Aguiar; L F Yuan; G Corradin; E Andersen; B Wizel; R A Houghten; A Oloo; P De la Vega; S L Hoffman
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

7.  Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.

Authors:  D Lys Guilbride; Pawel Gawlinski; Patrick D L Guilbride
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

8.  Monoclonal antibodies to the circumsporozoite protein repeats of a Plasmodium vivax-like human malaria parasite and Plasmodium simiovale.

Authors:  V Udhayakumar; S H Qari; P Patterson; W E Collins; A A Lal
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

9.  Immunogenicity of recombinant proteins consisting of Plasmodium vivax circumsporozoite protein allelic variant-derived epitopes fused with Salmonella enterica Serovar Typhimurium flagellin.

Authors:  Monica Teixeira Andrade Leal; Ariane Guglielmi Ariza Camacho; Laís Helena Teixeira; Daniel Youssef Bargieri; Irene Silva Soares; Cibele Aparecida Tararam; Mauricio M Rodrigues
Journal:  Clin Vaccine Immunol       Date:  2013-07-17

Review 10.  Plasmodium vivax: who cares?

Authors:  Mary R Galinski; John W Barnwell
Journal:  Malar J       Date:  2008-12-11       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.